REFERENCES
1. Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al.; Peer Review Committee Members. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146:e334-482.
2. Erbel R, Aboyans V, Boileau C, et al. ; Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i leczenia chorób aorty. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Kardiol Pol. 2014;72:1169-252.
3. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J. 2007;15:100-8.
4. Ikonomidis JS, Jones JA, Barbour JR, et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation. 2006;114:I365-70.
5. He R, Guo DC, Estrera AL, et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. 2006;131:671-8.
6. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2021: an updated summary. Biomed Environ Sci. 2022;35:573-603.
7. Fattori R, Cao P, De Rango P, et al. Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol. 2013;61:1661-78.
8. Hagan PG, Nienaber CA, Isselbacher EM, et al. The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897-903.
9. Estrera AL, Miller CC 3rd, Safi HJ, et al. Outcomes of medical management of acute type B aortic dissection. Circulation. 2006;114:I384-9.
10. Evangelista A, Isselbacher EM, Bossone E, et al. ; IRAD Investigators. Insights from the international registry of acute aortic dissection: a 20-year experience of collaborative clinical research. Circulation. 2018;137:1846-60.
14. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333-8.
15. Elia L, Quintavalle M, Zhang J, et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009;16:1590-8.
16. Ding W, Liu Y, Su Z, Li Q, Wang J, Gao Y. Emerging role of non-coding RNAs in aortic dissection. Biomolecules. 2022;12:1336.
17. Wang XJ, Huang B, Zhang L, et al. Differential gene expression in aortic tissues between patients with acute aortic dissection and normal controls. Chin J Mol Cardiol. 2014;14. 812-5. (in Chinese).
18. Guo DC, Regalado ES, Minn C, et al. Familial thoracic aortic aneurysms and dissections: identification of a novel locus for stable aneurysms with a low risk for progression to aortic dissection. Circ Cardiovasc Genet. 2011;4:36-42.
19. Huang W, Huang C, Ding H, et al. Involvement of miR-145 in the development of aortic dissection via inducing proliferation, migration, and apoptosis of vascular smooth muscle cells. J Clin Lab Anal. 2020;34:e23028.
20. Xiao Y, Sun Y, Ma X, et al. MicroRNA-22 inhibits the apoptosis of vascular smooth muscle cell by targeting p38MAPKα in vascular remodeling of aortic dissection. Mol Ther Nucleic Acids. 2020;22:1051-62.
21. Zou S. Analysis of microRNA expression and regulatory mechanisms in Stanford type A aortic dissection. Dissertation, University of South China, Hunan, 2015. (in Chinese). Available from: https://med.wanfangdata.com.cn/Paper/Detail?dbid=WF_XW&id=DegreePaper_D774884. [Last accessed on 2 June 2026].
22. Wang Z, Zhuang X, Chen B, Feng D, Li G, Wei M. The role of miR-107 as a potential biomarker and cellular factor for acute aortic dissection. DNA Cell Biol. 2020;39:1895-906.
23. Tang Y, Yu S, Liu Y, Zhang J, Han L, Xu Z. MicroRNA-124 controls human vascular smooth muscle cell phenotypic switch via Sp1. Am J Physiol Heart Circ Physiol. 2017;313:H641-9.
24. Wang Y, Dong CQ, Peng GY, et al. MicroRNA-134-5p regulates media degeneration through inhibiting VSMC phenotypic switch and migration in thoracic aortic dissection. Mol Ther Nucleic Acids. 2019;16:284-94.
25. Shao Y. The role of miR200c-3p in regulating endothelial cell apoptosis and proliferation and vascular smooth muscle cell phenotypic switching in aortic dissection. Dissertation, Chongqing Medical University, Chongqing, 2022. (in Chinese).
26. Ren M, Wang T, Wei X, et al. LncRNA H19 regulates smooth muscle cell functions and participates in the development of aortic dissection through sponging miR-193b-3p. Biosci Rep. 2021;41.
27. Song Y, Wang T, Mu C, Gui W, Deng Y, Ma R. LncRNA SENCR overexpression attenuated the proliferation, migration and phenotypic switching of vascular smooth muscle cells in aortic dissection via the miR-206/myocardin axis. Nutr Metab Cardiovasc Dis. 2022;32:1560-70.
28. Zhang K, Qi Y, Wang M, Chen Q. Long non-coding RNA HIF1A-AS2 modulates the proliferation, migration, and phenotypic switch of aortic smooth muscle cells in aortic dissection via sponging microRNA-33b. Bioengineered. 2022;13:6383-95.
29. Li S, Zhao X, Cheng S, Li J, Bai X, Meng X. Downregulating long non-coding RNA PVT1 expression inhibited the viability, migration and phenotypic switch of PDGF-BB-treated human aortic smooth muscle cells via targeting miR-27b-3p. Hum Cell. 2021;34:335-48.
30. Zhao X, Cheng S, Li S, Li J, Bai X, Xi J. CDKN2B-AS1 aggravates the pathogenesis of human thoracic aortic dissection by sponge to miR-320d. J Cardiovasc Pharmacol. 2020;76:592-601.
31. Lai Y, Li J, Zhong L, et al. The pseudogene PTENP1 regulates smooth muscle cells as a competing endogenous RNA. Clin Sci. 2019;133:1439-55.
32. Zhang X, Wu H, Mai C, Qi Y. Long noncoding RNA XIST/miR-17/PTEN axis modulates the proliferation and apoptosis of vascular smooth muscle cells to affect stanford type a aortic dissection. J Cardiovasc Pharmacol. 2020;76:53-62.
33. Wang W, Liu Q, Wang Y, et al. LINC01278 sponges miR-500b-5p to regulate the expression of ACTG2 to control phenotypic switching in human vascular smooth muscle cells during aortic dissection. J Am Heart Assoc. 2021;10:e018062.
34. Lin Y, Huang H, Yu Y, et al. Long non-coding RNA RP11-465L10.10 promotes vascular smooth muscle cells phenotype switching and MMP9 expression via the NF-κB pathway. Ann Transl Med. 2021;9:1776.
35. Liu Y, Wang L, Lei D, et al. Circ_0000006 and circ_0000160 regulate hsa-let-7e-5p/UBQLN4 axis in aortic dissection progression. PLoS One. 2024;19:e0304668.
36. Huang MX, Piao HL, Wang Y, et al. Circ_0022920 maintains the contractile phenotype of human aortic vascular smooth muscle cells via sponging microRNA-650 and promoting transforming growth factor beta receptor 1 expression in angiotensin II-induced models for aortic dissection. J Am Heart Assoc. 2023;12:e027425.
37. Cao X, Fang H, Zhou L. CircNRIP1 promotes proliferation, migration and phenotypic switch of Ang II-induced HA-VSMCs by increasing CXCL5 mRNA stability via recruiting IGF2BP1. Autoimmunity. 2024;57:2304820.
38. Xu Z, Zhong K, Guo G, et al. circ_TGFBR2 inhibits vascular smooth muscle cells phenotypic switch and suppresses aortic dissection progression by sponging miR-29a. J Inflamm Res. 2021;14:5877-90.
39. Li M, Li G, Yang Y, et al. piRNA-823 is a novel potential therapeutic target in aortic dissection. Pharmacol Res. 2023;196:106932.
40. Xu J, Shi GP. Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta. 2014;1842:2106-19.
41. Tian T, Luo F, Zhao LP, et al. Research progress on the role and mechanism of extracellular matrix in aortic aneurysm and aortic dissection. Chin J Clin Thorac Cardiovasc Surg. 2024;31. 1376-84. (in Chinese).
42. Sun YY. The role and mechanism of NANOG transcriptional regulation of miR-20a in promoting extracellular matrix degradation in the pathogenesis of thoracic aortic dissection. Dissertation, Naval Medical University, Shanghai, 2022.(in Chinese).
43. Wei Y, Yuan M, Wei M, et al. Study on the role and mechanism of microRNA-183 in extracellular matrix remodeling of acute aortic dissection. Chin J Mod Med. 2022;32:28-32.
44. Sun J, Chen G, Jing Y, et al. LncRNA expression profile of human thoracic aortic dissection by high-throughput sequencing. Cell Physiol Biochem. 2018;46:1027-41.
45. Zhang S, Zhao S, Han X, et al. Lnc-C2orf63-4-1 confers VSMC homeostasis and prevents aortic dissection formation via STAT3 interaction. Front Cell Dev Biol. 2021;9:792051.
46. Zou M, Huang C, Li X, et al. Circular RNA expression profile and potential function of hsa_circRNA_101238 in human thoracic aortic dissection. Oncotarget. 2017;8:81825-37.
47. Liu DB, He YF, Chen GJ, et al. Construction of a circRNA-Mediated ceRNA network reveals novel biomarkers for aortic dissection. Int J Gen Med. 2022;15:3951-64.
48. Liu X, Chen W, Zhu G, et al. Single-cell RNA sequencing identifies an Il1rn+/Trem1+ macrophage subpopulation as a cellular target for mitigating the progression of thoracic aortic aneurysm and dissection. Cell Discov. 2022;8:11.
49. Guo LL, Wu MT, Zhang LW, et al. Blocking interleukin-1 beta reduces the evolution of thoracic aortic dissection in a rodent model. Eur J Vasc Endovasc Surg. 2020;60:916-24.
50. Wu YW, Hu B, Guo XD, Fu Q, Zou ZJ. Effect of microRNA-30a regulation of mitogen-activated protein kinase pathway on aortic coarctation in rats. Acta Anat Sin 2024;55:222-8. (in Chinese).
51. Daniel F, Kalies K, Hehl L, et al. MicroRNA-127-3p regulates inflammatory response in injury-induced vascular remodeling and cellular senescence in vascular smooth muscle cells through mTor. Cardiovasc Res. 2024;120:cvae088.006.
52. Wang P. The mechanism of Lnc-OIP5-AS1 competitively binding to miR-143-3p in the pathogenesis of aortic dissection. Dissertation, Wuhan University, Wuhan, 2021. (in Chinese).
53. Wang K. Circular RNA hsa_circ_0079929 promotes endothelial inflammation in aortic dissection by activating PDE4D. Dissertation, Qingdao University, Shandong, 2023. (in Chinese).
54. Liang Q, Zhou Z, Li H, et al. Identification of pathological-related and diagnostic potential circular RNAs in Stanford type A aortic dissection. Front Cardiovasc Med. 2022;9:1074835.
55. Pape LA, Awais M, Woznicki EM, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the international registry of acute aortic dissection. J Am Coll Cardiol. 2015;66:350-8.
56. Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63-78.
57. Liao M, Zou S, Weng J, et al. A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to thoracic aortic dissection pathogenesis. J Vasc Surg. 2011;53:1341-1349.e3.
58. Boon RA, Seeger T, Heydt S, et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res. 2011;109:1115-9.
59. Xu Z, Wang Q, Pan J, et al. Characterization of serum miRNAs as molecular biomarkers for acute Stanford type A aortic dissection diagnosis. Sci Rep. 2017;7:13659.
60. Chai T, Yang X, Zhuang X, et al. Upregulation of miR-222-3p alleviates the symptom of aortic dissection through targeting STAT3. Life Sci. 2022;310:121051.
61. Zhang D, Zhao X, Wang B, Liu X, Aizezi A, Ma X. Circulating exosomal miRNAs as novel biomarkers for acute aortic dissection: a diagnostic accuracy study. Medicine. 2023;102:e34474.
62. Chen H, Li Y, Li Z, Shi Y, Zhu H. Diagnostic biomarkers and aortic dissection: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23:497.
63. Michalik KM, You X, Manavski Y, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114:1389-97.
64. Rodor J, Klimi E, Brown SD, et al. Functional screening identifies miRNAs with a novel function inhibiting vascular smooth muscle cell proliferation. Mol Ther. 2025;33:615-30.
65. Li Y, Maegdefessel L. Non-coding RNA contribution to thoracic and abdominal aortic aneurysm disease development and progression. Front Physiol. 2017;8:429.
66. He X, Wang S, Li M, et al. Long noncoding RNA GAS5 induces abdominal aortic aneurysm formation by promoting smooth muscle apoptosis. Theranostics. 2019;9:5558-76.
67. Tamblin-Hopper P, Kiss-Toth E, Sudbery I, et al. The potential therapeutic applications of long non-coding RNAs. J Transl Genet Genom. 2024;8:225-43.
68. He X, Li X, Han Y, et al. CircRNA Chordc1 protects mice from abdominal aortic aneurysm by contributing to the phenotype and growth of vascular smooth muscle cells. Mol Ther Nucleic Acids. 2022;27:81-98.
69. Dogra S, Kouznetsova VL, Kesari S, Tsigelny IF. Development of a miRNA-based deep learning model for autism spectrum disorder diagnosis. Adv Technol Neurosci. 2025;2:72-6.
70. Zhang RL, Wang WM, Li JQ, et al. The role of miR-155 in cardiovascular diseases: potential diagnostic and therapeutic targets. Int J Cardiol Cardiovasc Risk Prev. 2025;24:200355.
71. D’Alessandra Y, Valerio V, Moschetta D, et al. Extraction-free absolute quantification of circulating miRNAs by chip-based digital PCR. Biomedicines. 2022;10:1354.
72. Ferracin M, Negrini M. Quantification of circulating microRNAs by droplet digital PCR. In: Karlin-neumann G, Bizouarn F, editors. Digital PCR. New York: Springer; 2018. pp. 445-57.
73. Wang L, Zhang S, Xu Z, Zhang J, Li L, Zhao G. The diagnostic value of microRNA-4787-5p and microRNA-4306 in patients with acute aortic dissection. Am J Transl Res. 2017;9:5138-49.
74. Dong J, Bao J, Feng R, et al. Circulating microRNAs: a novel potential biomarker for diagnosing acute aortic dissection. Sci Rep. 2017;7:12784.
